Article
Survival outcomes of east Asian patients with advanced non-small cell lung cancer treated with first-line EGFR tyrosine kinase inhibitors: A network meta-analysis of real-world evidence.
Thoracic cancer - 1 Nov 2023
Chang Huang-Chih, Huang Kuo-Tung, Tseng Chia-Cheng, Chen Yu-Mu, Lai Chien-Hao, Chang Yu-Ping, Chen Yung-Che, Chuang Hung-Yi, Wang Chin-Chou
Abstract excerpt
BACKGROUND: The comparative efficacies of different generation tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer (NSCLC) remain largely unknown. Moreover, whether one EGFR-TKI confers superior survival remains unclear, especially in East Asians. We conducted a network meta-analysis (NMA) comparing the survival outcomes of East Asian patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.